L2 Asset Management »

Alnylam Pharmaceuticals shares owned by L2 Asset Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by L2 Asset Management from 13F filings

Historical chart of L2 Asset Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by L2 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by L2 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $279k 611 456.00

More positions owned by L2 Asset Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Meta Platforms Cl A (META)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
JPMorgan Chase & Co. (JPM)
NetApp (NTAP)
Logitech Intl S A SHS (LOGI)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for L2 Asset Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals